PureTech Health plc

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Site Specific
  • Medical Devices
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule

Other Names/Subsidiaries

  • Vedanta Biosciences, Inc.
  • Alivio Therapeutics, Inc.
  • resTORbio, Inc.
  • Tal Medical
See more in Biomedtracker

Latest on PureTech Health plc

Scrip

Spotlight On IPF Successors To Esbriet And Ofev

 
• By Kevin Grogan and Alexandra Shimmings

The busy week for the idiopathic pulmonary fibrosis (IPF) space has continued apace with the news that Roche is selling off rights to one of the two drugs currently approved for the debilitating and f

Scrip

ELEVATE Data Raise PureTech’s IPF Prospects

 
• By Kevin Grogan

PureTech Health’s bid to change the treatment paradigm for idiopathic pulmonary fibrosis (IPF) has been boosted by mid-stage data on its candidate that appears to have overcome the tolerability issues

Scrip

Finance Watch: PureTech’s Seaport Raises $225m For Depression, Anxiety Trials

 
• By Mandy Jackson

PureTech Health plc, after the multibillion-dollar success of its last neuropsychiatry venture Karuna Therapeutics Inc., launched Seaport Therapeutics in April with $100m in series A funding and on 21

Scrip

Hub and Spoke Model Paying Off Handsomely For PureTech

 
• By Kevin Grogan

New PureTech Health plc CEO Bharatt Chowrira has been reflecting on a successful first six months of the year, with both the firm's wholly owned pipeline and those of its subsidiaries progressing we